Racial, ethnic, and sex disparities in buprenorphine treatment from emergency departments by discharge diagnosis
Academic Emergency Medicine · 2025
DOI: 10.1111/acem.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Emergency Medicine, 2025. Verfasst von Neeraj Chhabra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, University of Illinois Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Buprenorphine, Emergency Service, Hospital, Healthcare Disparities, Opioid-Related Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Objectives
Racial and sex disparities are noted in the administration and prescribing of buprenorphine from emergency departments (EDs) nationally. It is unknown whether disparities persist when accounting for the specific discharge diagnosis addressed during encounters such as opioid overdose or withdrawal.
Methods
We conducted a cross‐sectional analysis of opioid‐related ED encounters from January 2020 through December 2023 using a national database, Epic Cosmos. We analyzed the effect of opioid encounter subtype—overdose or withdrawal—on receipt of buprenorphine using multivariable logistic regression adjusting for demographics and measured confounding variables. Encounter subtypes were defined by diagnosis codes and buprenorphine receipt was defined as administration or prescribing. We evaluated for racial, ethnic, and sex disparities within encounter subtypes for withdrawal and overdose.
Results
We examined 1,088,033 opioid‐related encounters. Adjusted odds for buprenorphine receipt were greater for encounters involving withdrawal (odds ratio [OR] 2.22, 95% CI 2.18–2.26), though reduced for overdose (OR 0.52, 95% CI 0.51–0.53) and other opioid complications (OR 0.69, 95% CI 0.64–0.70). Males were more likely to receive buprenorphine (OR 1.18, 95% CI 1.16–1.19) than females. All racial minorities excepting American Indian/Native American patients (OR 1.04, 95% CI 1.00–1.08) were less likely to receive buprenorphine than White patients (Asian OR 0.85, 95% CI 0.79–0.81; Black OR 0.80, 95% CI 0.79–0.81; Native Hawaiian/Pacific Islander OR 0.79, 95% CI 0.71–0.89). Subtype analyses indicated decreased odds for buprenorphine receipt for female patients across all subtypes. An increased odds for buprenorphine receipt among Black patients (OR 1.04, 95% CI 1.01–1.07; ref. White race) was noted in encounters involving opioid withdrawal but disparities persisted for opioid overdose.
Conclusions
The administration and prescribing of buprenorphine in the ED is heavily influenced by the presence of opioid withdrawal. Disparities disadvantage female patients and racial minorities. Some racial disparities, particularly among Black patients, are not evident when solely considering encounters involving opioid withdrawal. System‐level interventions are needed to address disparities and improve the equitable uptake of ED‐initiated buprenorphine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, University of Illinois Chicago, Chicago, Illinois, USA.
- AI.Health4All Center for Health Equity Using Machine Learning and Artificial Intelligence, Chicago, Illinois, USA.
- Institute for Research on Addictions, University of Illinois Chicago, Chicago, Illinois, USA.
- Department of Psychiatry, University of Illinois Chicago, Chicago, Illinois, USA.
- Natural Language Processing Laboratory, Department of Computer Science, University of Illinois Chicago, Chicago, Illinois, USA.
- University of Illinois College of Medicine, Chicago, Illinois, USA.
ORCID-Profile: Neeraj Chhabra, Natalie Parde, R Andrew Taylor, Gail D'Onofrio
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Chhabra, N., Smith, D., Parde, N., Hsing-Smith, N., Bianco, J. M., Taylor, R. A., D'Onofrio, G., & Karnik, N. S. (2025). Racial, ethnic, and sex disparities in buprenorphine treatment from emergency departments by discharge diagnosis. Academic Emergency Medicine. https://doi.org/10.1111/acem.70035
Vancouver
Chhabra N, Smith D, Parde N, Hsing-Smith N, Bianco JM, Taylor RA, et al. Racial, ethnic, and sex disparities in buprenorphine treatment from emergency departments by discharge diagnosis. Academic Emergency Medicine. 2025. doi:10.1111/acem.70035
BibTeX
@article{Chhabra2025,
author = {Chhabra, Neeraj and Smith, Dale and Parde, Natalie and Hsing-Smith, Nicole and Bianco, Joseph M and Taylor, R Andrew and D'Onofrio, Gail and Karnik, Niranjan S},
title = {Racial, ethnic, and sex disparities in buprenorphine treatment from emergency departments by discharge diagnosis},
journal = {Academic Emergency Medicine},
year = {2025},
doi = {10.1111/acem.70035}
}
EUVIMED